Molecular Medicine and Gene Therapy

Faculty of Medicine | Lund University


Molecular Medicine and Gene Therapy

bmc view banner

The Division of Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. Established as a joint venture between the Medical Faculty at Lund University and the Hematology Clinic at Lund University Hospital, our mission is to translate basic science to clinical applications.

Our research focuses on hematopoiesis, the continuous and dynamic process of blood cell formation. The laboratory consists of eight closely collaborating research groups that all share a common interest in investigating the properties of blood stem cells to eventually understand and treat hematological disorders.

Five of our researchers belong to the Hemato-Linné Excellence Linnaeus Research Environment funded by The Swedish Research Council and Lund University. Several of the groups are engaged in StemTherapy, a Strategic Research Area for Stem Cells and Regenerative Medicine that is also supported by The Swedish Research Council.


niels bjarne woods

Stem Cell Talks by Niels-Bjarne Woods "De novo generation of hematopoietic stem cells: What’s the problem?" 

When? Wednesday, February 15, 2017 at 14:45 

Where? Segerfalk Lecture Hall, BMC A10 


matilda wessman

Please welcome Matilda Wessman to the Singbrant Söderberg group. Matilda will be working on her Bachelor thesis during the spring and then continue as a summer project student. Her project will focus on the involvement of mitochondrial function in erythroid development in normal human hematopoietic stem and progenitor cells and myelodysplastic syndrome, MDS.

Welcome to our Division Matilda!

johan flygare
Johan Flygare

Stem Cell Talk by Johan Flygare "Novel approaches for anaemia therapy based on mechanisms regulating red blood cell production". 

When? Wednesday, January 25, 2017 at 14:45 

Where? Belfrage Lecture Hall, BMC AD15 


leal oburoglu

Congratulations to Leal Oburoglu who was awarded a prestigious EMBO Long-Term Fellowship. The EMBO Long-Term Fellowships are awarded for a period of up to two years and support postdoctoral research visits to laboratories throughout Europe and the world. International exchange is a key feature in the application process.

Leal, who joined the Woods group in February 2016, will be working on the metabolic control of iPS cell generation during her postdoctoral studies.

The Swedish Childhood Cancer Foundation has taken decisions on applications in the autumn's open call for research projects within the area of childhood cancer diseases. Three project grants were awarded to researchers at the Divisions of Molecular Hematology and Molecular Medicine and Gene Therapy. We congratulate Jenny Hansson, Cornelis Jan Pronk, and Stefan Karlsson on their success in receiving funding.

Site overview